Previous studies have found that obesity had an inhibitory effect on FSH levels[8] and weight loss decreased FSH levels in overweight postmenopausal women.[9] These findings may exist because there may be due to a possible inhibitory effect of body mass on gonadotropin.[10] However, in our study, the association between FSH and LDL-C remained significant even after adjusting for BMI, indicating that the association between FSH and LDL-C was independent of BMI. Here, BRD2 is linked to obesity due to melanocortin 4 receptor deficiency.